Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $4.9 million.

  • Eton Pharmaceuticals' Prepaid Assets rose 15227.16% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 15227.16%. This contributed to the annual value of $5.5 million for FY2024, which is 38644.82% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Prepaid Assets is $4.9 million, which was up 15227.16% from $4.8 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Prepaid Assets' 5-year high stood at $5.5 million during Q4 2024, with a 5-year trough of $541000.0 in Q3 2023.
  • Its 5-year average for Prepaid Assets is $2.2 million, with a median of $1.7 million in 2021.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Prepaid Assets crashed by 5939.57% in 2022, and later surged by 50325.41% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Prepaid Assets (Quarter) stood at $3.2 million in 2021, then crashed by 59.4% to $1.3 million in 2022, then dropped by 12.48% to $1.1 million in 2023, then skyrocketed by 386.45% to $5.5 million in 2024, then dropped by 10.01% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $4.8 million for Q2 2025, and $2.5 million during Q1 2025.